Tralau C J, MacRobert A J, Coleridge-Smith P D, Barr H, Bown S G
Br J Cancer. 1987 Apr;55(4):389-95. doi: 10.1038/bjc.1987.78.
Photodynamic therapy (PDT) is a promising approach to the local destruction of malignant tumours, but little work has been done to determine which factors control the extent of tissue necrosis produced. Using a new photosensitiser, a sulphonated aluminium phthalocyanine (AlSPc) and light from an argon ion pumped dye laser at 675 nm, we quantified the effects of interstitial PDT in a transplantable fibrosarcoma in rats. At 100mW laser power, thermal effects were comparable to those of PDT, so subsequent studies were carried out at 50 mW, where thermal effects were minimal. The depth of PDT necrosis increased with the logarithm of the applied energy. Tissue concentration of AlSPc was measured by alkali extraction and at all times after sensitisation, correlated well with the necrosis produced with a given light dose. Peak tumour concentration of AlSPc occurred 24-48 h after sensitisation compared with a peak at 3 h in muscle. The peak ratio tumour:muscle was 2:1 at 24 h. Apart from a different time interval to reach the peak sensitiser concentration, the extent of tumour damage varied with the light and sensitiser parameters in a similar way to that found in normal liver, although the optical penetration depth was greater in the tumour (2.5 mm vs. 1.8 mm). At doses of AlSPc below 1 mg kg-1 the diameter of necrosis increased with the logarithm of the dose of sensitiser, and doubling the dose from 0.25 to 0.5 mg kg-1 increased the depth of necrosis by 50%. However, at higher doses, the changes were smaller and increasing the dose from 2.5 to 5 mg kg-1 only increased the necrosis by 10% for the same light dose. In all dose ranges, a given percentage increase in the tissue concentration of AlSPc gave a much smaller percentage increase in the extent of necrosis for the same light dose, suggesting that selectivity of necrosis between tumour and normal tissue is likely to be much less than the selectivity of retention of the photosensitiser. From these results, the extent of PDT necrosis in this fibrosarcoma is as predictable as it is in normal liver if the light dose, tissue concentration of AlSPc and optical penetration depth of the tissue are known. Further studies are now required on different tumour models to establish how tumours respond compared with adjacent normal tissue when the tumour is growing in its organ of origin rather than the non-physiological situation using a transplantable tumour as in this study.
光动力疗法(PDT)是一种有前景的局部破坏恶性肿瘤的方法,但在确定哪些因素控制所产生的组织坏死程度方面,所做的工作很少。我们使用一种新的光敏剂——磺化铝酞菁(AlSPc)以及氩离子泵浦染料激光器在675nm波长下发出的光,对大鼠可移植性纤维肉瘤中的间质光动力疗法的效果进行了量化。在100mW激光功率下,热效应与光动力疗法的热效应相当,因此后续研究在50mW功率下进行,此时热效应最小。光动力疗法坏死的深度随施加能量的对数增加而增加。通过碱萃取法测量了AlSPc的组织浓度,在致敏后的所有时间点,其与给定光剂量产生的坏死情况相关性良好。与肌肉中在3小时达到峰值相比,AlSPc在肿瘤中的峰值浓度在致敏后24 - 48小时出现。在24小时时肿瘤与肌肉的峰值浓度比为2:1。除了达到峰值致敏剂浓度的时间间隔不同外,肿瘤损伤程度随光和致敏剂参数的变化方式与在正常肝脏中发现的相似,尽管肿瘤中的光穿透深度更大(2.5mm对1.8mm)。在AlSPc剂量低于1mg kg - 1时,坏死直径随致敏剂剂量的对数增加而增加,将剂量从0.25mg kg - 1增加到0.5mg kg - 1使坏死深度增加了50%。然而,在更高剂量下,变化较小,对于相同的光剂量,将剂量从2.5mg kg - 1增加到5mg kg - 1仅使坏死增加了10%。在所有剂量范围内,对于相同的光剂量,AlSPc组织浓度给定百分比的增加所导致的坏死程度增加百分比要小得多,这表明肿瘤与正常组织之间坏死的选择性可能远小于光敏剂保留的选择性。从这些结果来看,如果已知光剂量、AlSPc的组织浓度和组织的光穿透深度,那么这种纤维肉瘤中光动力疗法坏死的程度与正常肝脏中的一样可预测。现在需要对不同的肿瘤模型进行进一步研究,以确定当肿瘤在其原发器官中生长时,与使用本研究中可移植肿瘤这种非生理情况相比,肿瘤与相邻正常组织的反应情况。